| 000 | 01670 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513175410.0 | ||
| 264 | 0 | _c19990701 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0376-8716 | ||
| 024 | 7 |
_a10.1016/s0376-8716(98)00163-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGariti, P | |
| 245 | 0 | 0 |
_aCotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting. _h[electronic resource] |
| 260 |
_bDrug and alcohol dependence _cApr 1999 |
||
| 300 |
_a111-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aCholinergic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCotinine _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNicotine _xadministration & dosage |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aSmoking Cessation _xmethods |
| 650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xprevention & control |
| 650 | 0 | 4 |
_aTobacco Use Disorder _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAlterman, A I | |
| 700 | 1 | _aBarber, W | |
| 700 | 1 | _aBedi, N | |
| 700 | 1 | _aLuck, G | |
| 700 | 1 | _aCnaan, A | |
| 773 | 0 |
_tDrug and alcohol dependence _gvol. 54 _gno. 2 _gp. 111-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0376-8716(98)00163-x _zAvailable from publisher's website |
| 999 |
_c10176749 _d10176749 |
||